These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 39075995

  • 1. [Interim efficacy of a multicenter cohort study for China Net Childhood Lymphoma mature B-cell lymphoma 2017 regimen in the treatment of pediatric High-grade-B cell lymphoma].
    Zhao Y, Huang S, Jia YP, Zhang LP, Duan YL, Jin L, Zhai XW, Wang HS, Hu B, Liu Y, Liu AS, Liu W, Zheng MC, Li F, Sun LR, Yuan XJ, Dai YP, Zhang BX, Jiang L, Wang XG, Wang HM, Zhou CJ, Gao ZF, Zhang YH.
    Zhonghua Yi Xue Za Zhi; 2024 Jul 30; 104(29):2751-2758. PubMed ID: 39075995
    [Abstract] [Full Text] [Related]

  • 2. [Mid-term efficacy of China Net Childhood Lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
    Zhang M, Wu P, Duan YL, Jin L, Yang J, Huang S, Liu Y, Hu B, Zhai XW, Wang HS, Fu Y, Li F, Yang XM, Liu AS, Qin S, Yuan XJ, Dong YS, Liu W, Zhou JW, Zhang LP, Jia YP, Wang J, Qu LJ, Dai YP, Guan GT, Sun LR, Jiang J, Liu R, Jin RM, Wang ZJ, Wang XG, Zhang BX, Chen KL, Zhuang SQ, Zhang J, Zhou CJ, Gao ZF, Zheng MC, Zhang Y.
    Zhonghua Er Ke Za Zhi; 2022 Oct 02; 60(10):1011-1018. PubMed ID: 36207847
    [Abstract] [Full Text] [Related]

  • 3. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, Rushton C, Tang J, Thomas N, Slack GW, Farinha P, Takata K, Miyata-Takata T, Craig J, Mottok A, Meissner B, Saberi S, Bashashati A, Villa D, Savage KJ, Sehn LH, Kridel R, Mungall AJ, Marra MA, Shah SP, Steidl C, Connors JM, Gascoyne RD, Morin RD, Scott DW.
    J Clin Oncol; 2019 Jan 20; 37(3):190-201. PubMed ID: 30523716
    [Abstract] [Full Text] [Related]

  • 4. High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL.
    Li S, Qiu L, Xu J, Lin P, Ok CY, Tang G, McDonnell TJ, James You M, Khanlari M, Miranda RN, Medeiros LJ.
    Leukemia; 2023 Feb 20; 37(2):422-432. PubMed ID: 36513804
    [Abstract] [Full Text] [Related]

  • 5. [Clinicopathological features and prognosis of high-grade B-cell lymphoma with MYC and bcl-2 and/or bcl-6 rearrangements].
    Shen X, Zhou LT, Li AQ, Yi HM, Ouyang BS, Xu HM, Xie JL, Gu YJ, Zhang L, Dong L.
    Zhonghua Bing Li Xue Za Zhi; 2022 Feb 08; 51(2):120-125. PubMed ID: 35152630
    [Abstract] [Full Text] [Related]

  • 6. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
    Misyurina AE, Kravchenko SK, Kovrigina AM, Magomedova AU, Plastinina LV, Obukhova TN, Misyurin AV, Misyurin VA, Grebenuk LA, Babaeva FE, Baryakh EA, Vorobiev AI.
    Ter Arkh; 2019 Jul 15; 91(7):52-62. PubMed ID: 32598736
    [Abstract] [Full Text] [Related]

  • 7. The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified.
    Qiu L, Lin P, Khanlari M, Xu J, Cohen EN, Garces S, Miranda RN, Wang W, Fang H, Bueso-Ramos CE, Medeiros LJ, Li S.
    Mod Pathol; 2023 Dec 15; 36(12):100349. PubMed ID: 37820764
    [Abstract] [Full Text] [Related]

  • 8. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: Biopsy analysis of 70 cases from the Slovak Lymphoma Registry.
    Lešková K, Szépe P, Balhárek T, Barthová M, Janáková Ľ, Farkašová A, Plank L.
    Neoplasma; 2022 Jul 15; 69(4):957-964. PubMed ID: 35652622
    [Abstract] [Full Text] [Related]

  • 9. [Treatment strategy for high-grade B-cell lymphoma].
    Maruyama D.
    Rinsho Ketsueki; 2018 Jul 15; 59(10):2109-2116. PubMed ID: 30305516
    [Abstract] [Full Text] [Related]

  • 10. High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.
    Scott DW, King RL, Staiger AM, Ben-Neriah S, Jiang A, Horn H, Mottok A, Farinha P, Slack GW, Ennishi D, Schmitz N, Pfreundschuh M, Nowakowski GS, Kahl BS, Connors JM, Gascoyne RD, Ott G, Macon WR, Rosenwald A.
    Blood; 2018 May 03; 131(18):2060-2064. PubMed ID: 29475959
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphoma.
    Cho YA, Hyeon J, Lee H, Cho J, Kim SJ, Kim WS, Ko YH.
    Hum Pathol; 2021 Jul 03; 113():9-19. PubMed ID: 33771538
    [Abstract] [Full Text] [Related]

  • 13. High-grade B-cell lymphoma with a quadruple-hit genetic profile including concurrent MYC, BCL2, BCL6, and CCND1 gene rearrangements.
    Gagnon MF, Meyer RG, Weaver EJ, Wood AJ, Dupuy DA, Menachery SJ, Shi M, Baughn LB, Ketterling RP, Peterson JF.
    Lab Med; 2024 Sep 04; 55(5):649-654. PubMed ID: 38522075
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term efficacy and prognostic factors of Beijing Children's Hospital-2009-lymphoblastic lymphoma in the treatment of T-lymphoblastic lymphoma in children and adolescents].
    Jin L, Yang J, Duan YL, Huang S, Zhang M, Zhou CJ, Zhang NN, Zhang YH.
    Zhonghua Yi Xue Za Zhi; 2024 Jul 30; 104(29):2759-2766. PubMed ID: 39075996
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.